Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line theraphy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE):an open-label randomised, controlled phase 3 trial. Lancet Oncology
Online resources: https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S1470204515000212?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1470204515000212%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.ncbi.nlm.nih.gov%2F| Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
| Faculty Research | St Luke's College of Medicine Library Special Collections | F 2015-23 (Browse shelf) | Not For Loan (Restricted Access) | F 2015-23 |
There are no comments on this title.